Challenges of identifying cancer patients for randomised controlled trials (RCTs) from urology clinics: what lessons can we learn from SPARE? (CRUK/07/011)


Year:

Session type:

Rebecca Lewis1, Robert Huddart1, Alison Birtle2, Jane Blazeby3, Emma Jones1, Emma Hall1, behalf of SPARE TMG1

1The Institute of Cancer Research, Sutton, UK, 2Lancashire Teaching Hospitals, Preston, UK, 3University of Bristol, UK

Abstract

Background

Historically, RCTs of urological cancer treatments have been predominantly conducted within oncology clinics.